Literature DB >> 1629508

Biochemical variability of venoms from individual European and Africanized honeybees (Apis mellifera).

M J Schumacher1, J O Schmidt, N B Egen, K A Dillon.   

Abstract

To study biochemical differences between venom from individual honeybees, venom sacs from 103 European (EU) bees and 92 Africanized bees representing 12 different colonies were dissected, and the dry weight (DW) of venom from each bee was determined. Venom from each of these bees was studied with isoelectric focusing and functional assays for phospholipase A2 and melittin. Phospholipase concentrations in individual EU bee venoms varied between 1.8% and 27.4% (wt/wt). The melittin concentration in EU bee venom varied less and, on the average, was found to be much lower than previously reported. There was an eightfold to ninefold difference between lowest and highest venom sac DW contents, suggesting the possibility of highly variable venom delivery from bee stings. One EU bee contained greater than 300 micrograms of venom, three times the recommended maintenance dose for venom immunotherapy. Isoelectric focusing also demonstrated large differences between individual bees, with respect to major and minor components of their venoms. Africanized bees contained significantly less venom but more phospholipase than did EU bees. Bee venoms from different colonies differed in their DW content and in their concentrations of phospholipase and melittin. The results are relevant to the uncertainty of responses from sting challenges and field stings in allergic patients and massive stinging attacks on normal subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629508     DOI: 10.1016/s0091-6749(06)80011-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  New CZE-DAD method for honeybee venom analysis and standardization of the product.

Authors:  Zenon J Kokot; Jan Matysiak; Bartosz Urbaniak; Paweł Dereziński
Journal:  Anal Bioanal Chem       Date:  2011-01-08       Impact factor: 4.142

Review 2.  Melittin, the Major Pain-Producing Substance of Bee Venom.

Authors:  Jun Chen; Su-Min Guan; Wei Sun; Han Fu
Journal:  Neurosci Bull       Date:  2016-03-17       Impact factor: 5.203

Review 3.  The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword.

Authors:  Jun Chen; William R Lariviere
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

Review 4.  What physicians should know about Africanized honeybees.

Authors:  R A Sherman
Journal:  West J Med       Date:  1995-12

5.  De Novo sequencing and transcriptome analysis for Tetramorium bicarinatum: a comprehensive venom gland transcriptome analysis from an ant species.

Authors:  Wafa Bouzid; Marion Verdenaud; Christophe Klopp; Frédéric Ducancel; Céline Noirot; Angélique Vétillard
Journal:  BMC Genomics       Date:  2014-11-18       Impact factor: 3.969

Review 6.  Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy.

Authors:  Manuela B Pucca; Felipe A Cerni; Isadora S Oliveira; Timothy P Jenkins; Lídia Argemí; Christoffer V Sørensen; Shirin Ahmadi; José E Barbosa; Andreas H Laustsen
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

7.  Worldwide perspectives on venom allergy.

Authors:  Peter Korošec; Thilo Jakob; Harfi Harb; Robert Heddle; Sarah Karabus; Ricardo de Lima Zollner; Julij Selb; Bernard Yu-Hor Thong; Fares Zaitoun; David B K Golden; Michael Levin
Journal:  World Allergy Organ J       Date:  2019-10-24       Impact factor: 4.084

Review 8.  Analytical methods for honeybee venom characterization.

Authors:  Iouraouine El Mehdi; Soraia I Falcão; Saïd Boujraf; Harandou Mustapha; Maria G Campos; Miguel Vilas-Boas
Journal:  J Adv Pharm Technol Res       Date:  2022-07-05

9.  An evaluation of the chemical content and microbiological contamination of Anatolian bee venom.

Authors:  Aslı Elif Tanuğur-Samanc; Meral Kekeçoğlu
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.